Biogen Inc., 10% Owner at SANGAMO THERAPEUTICS, INC (SGMO), sold 6,000,000 shares at $0.50 ($3.0M) on 2023-09-26, disclosed to the SEC on 2023-09-28.
Open-market sale of $3.0M SGMO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SGMO | SELL | 2021-12-28 | $1.4M | — | Filing → |
| SGMO | SELL | 2021-12-10 | $405K | — | Filing → |
| SGMO | SELL | 2021-12-09 | $2.2M | — | Filing → |